Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinamide adenine dinucleotide (NAD⁺) synthesis pathway encompasses the biochemical routes by which cells generate NAD⁺, a vital coenzyme involved in redox reactions, energy metabolism, and cellular signaling. There are three primary pathways for NAD⁺ biosynthesis in mammals: de novo, Preiss–Handler, and salvage pathways. Key enzymes include NAMPT, QPRT, and NMNATs. The pathway is crucial for cellular energy status, gene regulation, and stress responses.
Regulation of NAD+ levels through modulation of key enzymes like NAMPT, QPRT, and NMNATs.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide Adenine Dinucleotide Synthesis Pathway (NAD⁺ Synthesis Pathway).